FENC - NASDAQ

Fennec Pharmaceuticals Inc.

FENC·NASDAQ

$9.35

-6.3%

HealthcareBiotechnology

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$267.13M

EPS-0.3600

P/E Ratio-25.96

Earnings Date08/13/2026

fenc

Other Current Assets

Last Annual Value

1.37M

3-Year CAGR

179%

5-Year CAGR

38%

10-Year CAGR

106%

Adjust for Inflation

Fennec Pharmaceuticals Inc. Competitors Analysis of Other Current Assets

FENC · NASDAQ

Company	Other Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Fennec Pharmaceuticals Inc. NASDAQ:FENC	1.37M	214.7%	40.2%	84.5%
Orchestra BioMed Holdings, Inc. NASDAQ:OBIO	994.00K	-7.9%	N/A	N/A
Black Diamond Therapeutics, Inc. NASDAQ:BDTX	3.79M	12.9%	N/A	N/A
Assembly Biosciences, Inc. NASDAQ:ASMB	5.47M	16.1%	N/A	N/A
Immuneering Corporation NASDAQ:IMRX	3.41M	-0.0%	N/A	N/A
SELLAS Life Sciences Group, Inc. NASDAQ:SLS	3.32M	221.3%	161.8%	44.3%
Sagimet Biosciences Inc. NASDAQ:SGMT	3.28M	102.2%	16.8%	N/A
Entrada Therapeutics, Inc. NASDAQ:TRDA	10.55M	-4.0%	N/A	N/A
Zura Bio Limited NASDAQ:ZURA	2.90M	40.9%	N/A	N/A
Caribou Biosciences, Inc. NASDAQ:CRBU	2.91M	33.7%	34.1%	N/A
Cartesian Therapeutics, Inc. NASDAQ:RNAC	3.02M	-15.3%	N/A	44.2%

Fennec Pharmaceuticals Inc. Fair Value Envelope

FENC · NASDAQ

Our analysis suggests that FENC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $9.3467, this represents a potential HIDDEN relative to our calculated worth for Fennec Pharmaceuticals Inc..

HIDDEN

Intrinsic Value

Current Price: $9.3467

Related Guides

Blog Categories

Continue your FENC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.